QuidelOrtho Corporation Investor Presentation — August 2022

Document content

Forging the Future of Diagnostics

Financial Results 2Q 2022

August 4, 2022 © QuidelOrtho 2022 2Forward -Looking Statements

Forward -Looking Statements: This presentation of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) contains “forward -looking statements” within the

meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward -looking sta tements in this presentation by words such

as “may,” “will,” “would,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “continue,” or similar words, exp ressions or the negative of such terms or other

comparable terminology. These statements include, but are not limited to, the benefits and results of the business combinatio n by and among QuidelOrtho, Quidel

Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc (“Ortho”) and certain other entities (the “Combinations”) and integration of the businesses of Quidel and

Ortho, including QuidelOrtho’s execution of cost and revenue synergies, commercial and other strategic goals, future financia l and operating results, future plans,

objectives, strategies, expectations and intentions and other statements that are not historical facts. Such statements are b ased on the current beliefs and expectations of

QuidelOrtho’s management and are subject to significant risks and uncertainties. Actual results may differ significantly from those set forth in the forward -looking

statements. The following factors, among others, could cause actual results to differ from those set forth in the forward -lookin g statements: the challenges and costs of

integrating, restructuring and achieving anticipated synergies as a result of the Combinations; the ability to retain key emp loyees; and other economic, business,